Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00143260|
Recruitment Status : Completed
First Posted : September 2, 2005
Last Update Posted : June 8, 2012
|Condition or disease||Intervention/treatment||Phase|
|Impotence||Drug: Viagra (Sildenafil Citrate) 100 mg||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||250 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Multicenter Randomized Double-Blind, Placebo-Controlled, Fixed-Dose Parallel Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose - II|
|Study Start Date :||August 2005|
|Actual Primary Completion Date :||May 2006|
|Actual Study Completion Date :||May 2006|
- To determine the proportion of sexual intercourses that are successful in men with mild to moderate ED 8 hrs after a dose of Viagra.
- Proportion (as above) of patients at various endpoints. Other questionnaires such as SEP, IIEF.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00143260
Show 25 Study Locations
|Study Director:||Pfizer CT.gov Call Center||Pfizer|